Chairman, CEO & President, TriVascular Technologies, Inc.
Christopher G. Chavez was appointed Chairman, CEO, and President of TriVascular, Inc. effective April 12, 2012. Chris joins TriVascular with over 30 years of leadership experience in the medical device industry. For the past six years, Chris served as President of the Neuromodulation Division (NMD) of St. Jude Medical. Chris joined St. Jude Medical through its acquisition of Advanced Neuromodulation Systems (ANS) in 2005. At ANS, Chris served as CEO, President and Director leading ANS/NMD through 14 years of profitable growth and innovation. Prior to ANS, Chris spent 17 years at Johnson & Johnson most recently as Vice President and General Manager of the Worldwide Infection Prevention Business. Chris has previously served as Chairman of the Medical Device Manufacturers Association, Chairman of the Dallas/Fort Worth Health Industry Council, and as a Board Member of Advanced Medical Optics, which was acquired by Abbott Laboratories in 2009. Chris received his MBA from the Harvard Business School and holds a bachelors degree in accounting from New Mexico State University.